UBS Group AG - PROFOUND MED CORP ownership

PROFOUND MED CORP's ticker is PROF and the CUSIP is 74319B502. A total of 42 filers reported holding PROFOUND MED CORP in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PROFOUND MED CORP
ValueSharesWeighting
Q4 2022$22,499
-6.3%
2,066
-65.2%
0.00%
Q3 2022$24,000
+2300.0%
5,944
+2799.5%
0.00%
Q2 2022$1,000
-93.8%
205
-85.6%
0.00%
Q4 2021$16,000
+166.7%
1,428
+376.0%
0.00%
Q1 2021$6,000
-87.2%
300
-87.0%
0.00%
Q4 2020$47,000
-4.1%
2,300
-17.6%
0.00%
Q3 2020$49,000
+16.7%
2,792
+13.0%
0.00%
Q2 2020$42,000
+23.5%
2,470
-30.3%
0.00%
Q1 2020$34,000
+325.0%
3,545
+406.4%
0.00%
Q4 2019$8,0007000.00%
Other shareholders
PROFOUND MED CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 543,601$8,878,00010.84%
GAGNON SECURITIES LLC 800,845$13,102,0001.86%
Gagnon Advisors, LLC 277,252$4,536,0001.72%
PCJ Investment Counsel Ltd. 165,220$2,690,0001.01%
Taylor Wealth Management Partners 166,321$2,721,0000.96%
Altium Capital Management LP 210,280$3,440,0000.80%
AWM Investment Company, Inc. 348,939$5,709,0000.56%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,297,797$21,232,0000.38%
PURA VIDA INVESTMENTS, LLC 644,273$10,540,0000.33%
Zweig-DiMenna Associates LLC 221,667$3,626,0000.22%
View complete list of PROFOUND MED CORP shareholders